Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

45.83 -2.28 (-4.74%)
Streaming Delayed Price Updated: 3:02 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
Investors can find much better opportunities. 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Monday? Find out below. ↗
Via Chartmill
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
Via Chartmill
News headline image
Moderna Recognized by TIME as One of the World's Most Impactful Companies
Via ACCESS Newswire
News headline image
Stock Market Today, May 11: Chipmakers Drive Midday Gains Despite Oil Concerns ↗
Today, May 11, 2026, AI chip leaders helped steady major U.S. indexes at midday as the Strait of Hormuz remains largely closed. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗
Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week. 
Via The Motley Fool
Topics Death
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
Via Investor Brand Network
Topics Intellectual Property
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
News headline image
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
From BioMedWire
Via GlobeNewswire
News headline image
3 Cash-Heavy Stocks with Warning Signs
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg... 
Via StockStory
News headline image
Moderna (MRNA) Shares Skyrocket, What You Need To Know
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 10.2% in the afternoon session after the company published positive Phase 3 clini... 
Via StockStory
Topics Intellectual Property
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Friday? ↗
Via Chartmill
News headline image
Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know ↗
Moderna Inc (NASDAQ: MRNA) shares are trading higher Friday morning as traders react to peer reviewed Phase 3 flu-vaccine data. 
Via Benzinga
News headline image
5 Insightful Analyst Questions From Moderna’s Q1 Earnings Call
Moderna’s first quarter was marked by a sharp increase in revenue, driven by the fulfillment of large international contracts, particularly through a strateg... 
Via StockStory
Topics Earnings Intellectual Property
News headline image
Moderna Stock Gives Back Early Gains: What's Happening? ↗
Moderna, Inc. (NASDAQ:MRNA) shares initially surged Thursday, but have since retreated after the company announced the publication of its Phase 3 study results evaluating mRNA -1010 in the New England... 
Via Benzinga
Top S&P500 movers in Thursday's pre-market session ↗
Via Chartmill
News headline image
Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
Via ACCESS Newswire
These S&P500 stocks are moving in today's session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
News headline image
MRNA Q1 Deep Dive: International Partnerships and Pipeline Progress Offset Litigation Headwinds
Biotechnology company Moderna (NASDAQ:MRNA) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 260% year on year to $389 mil... 
Via StockStory
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Moderna (MRNA) Q1 2026 Earnings Transcript ↗
Moderna (MRNA) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars
Biotechnology company Moderna (NASDAQ:MRNA) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 260% year on year to $389 mi... 
Via StockStory
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.